Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity - PubMed (original) (raw)

Comparative Study

Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity

B S Bunney et al. Life Sci. 1978.

No abstract available

PubMed Disclaimer

Similar articles

• Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
  Arbilla S, Kamal LA, Langer SZ. Arbilla S, et al. Br J Pharmacol. 1981 Oct;74(2):389-97. doi: 10.1111/j.1476-5381.1981.tb09983.x. Br J Pharmacol. 1981. PMID: 7317688 Free PMC article.
• Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
  Argiolas A, Melis MR, Fadda F, Gessa GL. Argiolas A, et al. Brain Res. 1982 Feb 18;234(1):177-81. doi: 10.1016/0006-8993(82)90484-x. Brain Res. 1982. PMID: 6800566
• Zetidoline, a novel neuroleptic, activates nigral dopaminergic neurons in rats.
  Mereu G, Fanni B, Collu M, Diena A, Glasser A. Mereu G, et al. Life Sci. 1985 Feb 4;36(5):459-64. doi: 10.1016/0024-3205(85)90258-9. Life Sci. 1985. PMID: 2857469
• Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
  Biggio G, Corda MG, Casu M, Gessa GL. Biggio G, et al. Adv Biochem Psychopharmacol. 1978;18:227-44. Adv Biochem Psychopharmacol. 1978. PMID: 206110 Review. No abstract available.
• Is dopamine a transmitter in the periphery?
  Hadjiconstantinou M, Neff NH. Hadjiconstantinou M, et al. Neuropharmacology. 1987 Jul;26(7B):809-14. doi: 10.1016/0028-3908(87)90056-6. Neuropharmacology. 1987. PMID: 2889155 Review.

Cited by

• Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons.
  Ungless MA, Grace AA. Ungless MA, et al. Trends Neurosci. 2012 Jul;35(7):422-30. doi: 10.1016/j.tins.2012.02.003. Epub 2012 Mar 28. Trends Neurosci. 2012. PMID: 22459161 Free PMC article. Review.
• Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.
  Allard P, Eriksson K, Ross SB, Marcusson JO. Allard P, et al. Psychopharmacology (Berl). 1990;102(3):291-4. doi: 10.1007/BF02244092. Psychopharmacology (Berl). 1990. PMID: 1979175
• Implications of cellular models of dopamine neurons for schizophrenia.
  Yu N, Tucker KR, Levitan ES, Shepard PD, Canavier CC. Yu N, et al. Prog Mol Biol Transl Sci. 2014;123:53-82. doi: 10.1016/B978-0-12-397897-4.00011-5. Prog Mol Biol Transl Sci. 2014. PMID: 24560140 Free PMC article. Review.
• Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons.
  Moore H, Todd CL, Grace AA. Moore H, et al. J Neurosci. 1998 Jul 1;18(13):5068-77. doi: 10.1523/JNEUROSCI.18-13-05068.1998. J Neurosci. 1998. PMID: 9634572 Free PMC article.
• The acute effect of sertindole on brain 5-HT2, D2 and alpha 1 receptors (ex vivo radioreceptor binding studies).
  Hyttel J, Nielsen JB, Nowak G. Hyttel J, et al. J Neural Transm Gen Sect. 1992;89(1-2):61-9. doi: 10.1007/BF01245352. J Neural Transm Gen Sect. 1992. PMID: 1329856

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database